Literature DB >> 8740233

Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.

J Verschuuren1, L Chuang, M K Rosenblum, F Lieberman, A Pryor, J B Posner, J Dalmau.   

Abstract

We studied the nervous systems and tumors of two patients with anti-Yo-associated paraneoplastic cerebellar degeneration (PCD). In both patients the underlying tumor was an ovarian adenocarcinoma that expressed Yo antigens and contained extensive infiltrates of lymphocytes and plasma cells. The major central nervous system findings were a complete loss of cerebellar Purkinje cells with Bergmann astrogliosis. One patient had inflammatory infiltrates in the medulla and pons, and moderate axonal loss and demyelination involving the spinal cord. No inflammatory infiltrates were identified in the cerebrum, cerebellum or brain-stem of the other patient. Using quantitative Western blot analysis, deposits of anti-Yo IgG could not be demonstrated in the nervous system, possibly as a result of the loss of cells expressing Yo antigens. The detection of the anti-Yo antibody as a common marker of PCD in one patient with inflammatory infiltrates and another without infiltrates suggests that some PCD pathologically classified as "non-inflammatory" may represent a final burn-out stage of a cellular immune-mediated disorder. Our findings indicate that Purkinje cells are the main, but not necessarily the exclusive, targets of this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740233     DOI: 10.1007/s004010050460

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

1.  Synthetic consciousness: the distributed adaptive control perspective.

Authors:  Paul F M J Verschure
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-19       Impact factor: 6.237

2.  Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.

Authors:  Kazuyuki Ishida; Hiroshi Mitoma; Yoshiaki Wada; Teruaki Oka; Junji Shibahara; Yuko Saito; Shigeo Murayama; Hidehiro Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-21       Impact factor: 10.154

3.  Unusual MRI abnormalities in anti-Yo positive "pure" paraneoplastic cerebellar degeneration.

Authors:  John C McHugh; Niall Tubridy; Conor D Collins; Michael Hutchinson
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

Review 4.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

Review 5.  Immunity and Inflammation in Epilepsy.

Authors:  Annamaria Vezzani; Bethan Lang; Eleonora Aronica
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

6.  A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues.

Authors:  J P Corradi; C Yang; J C Darnell; J Dalmau; R B Darnell
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

Review 7.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

8.  Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.

Authors:  K-D Choi; J S Kim; S-H Park; Y K Kim; S E Kim; P S Smitt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

9.  Essential tremor is not a neurodegenerative disease.

Authors:  Ali H Rajput; Charles H Adler; Holly A Shill; Alex Rajput
Journal:  Neurodegener Dis Manag       Date:  2012-06

10.  Rapid Eye Movement Sleep Behavior Disorder in Paraneoplastic Cerebellar Degeneration: Improvement with Immunotherapy.

Authors:  Thiago Cardoso Vale; Lucila Bizari Fernandes do Prado; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini; José Luiz Pedroso
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.